Cellular studies on retinoblastoma.
Retinoblastoma may be hereditary or non-hereditary. The hereditary form involves either a predisposing gene transmissible as an autosomal dominant or a deletion at chromosome 13q14. An abnormal cellular response to ionizing radiation was suggested by the occurrence of secondary neoplasms within the field of therapeutic radiation in hereditary retinoblastoma patients. Hereditary retinoblastoma patients also show a predisposition to second neoplasms not related to therapy. In vitro studies on the radiation response of cells from retinoblastoma patients have generated conflicting results. Some laboratories, including our own, find that survival following ionizing irradiation of fibroblasts is within the normal range, other laboratories find an abnormal decrease in cell survival. X-ray-induced chromosome damage in G0-irradiated lymphocytes was slightly elevated compared to control subjects. Recent studies using chromosome 13 genetic markers suggest that retinoblastoma tumour cells are homo- or hemi-zygous for the mutant retinoblastoma gene. It seems unlikely that the mutant gene causes sensitivity to ionizing radiation but any tendency to chromosomal rearrangement in a gene carrier would increase the probability of tumour development.
D002460:Cell Line; D002470:Cell Survival / Q000528:radiation effects; D002872:Chromosome Deletion; D002901:Chromosomes, Human, 13-15; D004273:DNA, Neoplasm / Q000032:analysis; D004314:Down Syndrome / Q000235:genetics / Q000473:pathology; D005134:Eye Neoplasms / Q000235:genetics / Q000473:pathology*; D005347:Fibroblasts / Q000528:radiation effects; D005796:Genes; D006580:Genetic Carrier Screening; D005838:Genotype; D006801:Humans; D007399:Interphase; D008214:Lymphocytes / Q000528:radiation effects; D009154:Mutation; D012175:Retinoblastoma / Q000235:genetics / Q000473:pathology*
D004273:DNA, Neoplasm